Determination of the active metabolites of sibutramine in rat serum using column-switching HPLC. 2008

So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, Korea.

A simple and direct analysis using column-switching HPLC method was developed and validated for the quantification of active metabolites of sibutramine, N-mono-desmethyl metabolite (metabolite 1, M1) and N-di-desmethyl metabolite (metabolite 2, M2) in the serum of rats administered sibutramine HCl (5.0 mg/kg, p.o.). Rat serum was directly injected onto the precolumn without sample prepreparation step following dilution with mobile phase A, i. e., methanol-ACN-20 mM ammonium phosphate buffer (pH 6.0 with phosphoric acid) (8.3:4.5:87.2 by volume). After the endogenous serum components were eluted to waste, the system was switched and the analytes were eluted to the trap column. Active metabolites M1 and M2 were then back-flushed to the analytical column for separation with mobile phase B, i. e., methanol-ACN-20 mM ammonium phosphate buffer (pH 6.0 with phosphoric acid) (35.8:19.2:45 by volume) and detected at 223 nm. The calibration curves of active metabolites M1 and M2 were linear in the range of 0.1-1.0 microg/mL and 0.15-1.8 microg/mL. This method was fully validated and shown to be specific, accurate (10.4-10.7% error), and precise (1.97-8.79% CV). This simple and rapid analytical method using column-switching appears to be useful for the pharmacokinetic study of active metabolites (M1 and M2) of sibutramine.

UI MeSH Term Description Entries
D008297 Male Males
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
December 1994, Archives of pharmacal research,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
January 1993, Yao xue xue bao = Acta pharmaceutica Sinica,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
April 2016, The Analyst,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
May 2007, Biomedical chromatography : BMC,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
January 1989, Journal of pharmaceutical and biomedical analysis,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
April 1999, Journal of chromatography. B, Biomedical sciences and applications,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
January 2013, International journal of pharmaceutics,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
August 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
So Young Um, and Kyu-Bong Kim, and Seon Hwa Kim, and Young Cheol Ju, and Hye Sang Lee, and Hye young Oh, and Ki Hwan Choi, and Myeon Woo Chung
January 2010, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!